Skip to main content

Table 2 Median IC 50 for different diagnoses in response to VLX40

From: Screening for phenotype selective activity in multidrug resistant cells identifies a novel tubulin active agent insensitive to common forms of cancer drug resistance

Diagnosis Median IC50(μM) Number of samples
Breast cancer >34 8
Colon cancer >34 5
Lung cancer >34 6
Renal cancer >34 8
Ovarian cancer >34 19
AML 1.56 8
ALL 3.21 19
CML 0.98 2
CLL 2.18 11
NHL 0.51 13
PBMC 16.3 4